Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Schizophrenia Research
|
August 30, 2011
Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms
Deanna L Kelly, Gopal Vyas, Charles M Richardson, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
April 20, 2021
Feasibility and patient-reported satisfaction using a novel point-of-care fingerstick method for monitoring absolute neutrophil count for clozapine
Deanna L Kelly, Olga Y Ponomareva, Marie Mackowick, et al.
The Psychiatric Quarterly
|
June 24, 2017
Clozapine in Reducing Aggression and Violence in Forensic Populations
Kathleen Patchan, Gopal Vyas, Ann L Hackman, et al.
Schizophrenia Research
|
July 10, 2012
A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies
Jessica Jackson, William Eaton, Nicola Cascella, et al.
Schizophrenia Research
|
March 31, 2022
Anti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illness
Vincent S Cavaliere, Matthew Glassman, Bethany A DiPaula, et al.
The Psychiatric Quarterly
|
May 4, 2017
Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels
Heidi J Wehring, Teresa Elsobky, Joseph P McEvoy, et al.
Journal of Clinical Psychopharmacology
|
August 15, 2024
Prebiotic Treatment in People With Schizophrenia
Robert W Buchanan, Anne E Werkheiser, Hanna Michel, et al.
Frontiers in Psychiatry
|
December 8, 2025
Case Report: Metabolic, inflammatory, and neurological improvements after a ketogenic diet in a woman with treatment-resistant schizophrenia and metabolic syndrome
Sidney L Murray, Gopal Vyas, Erich Eberhardt, et al.
Clinical Schizophrenia & Related Psychoses
|
July 29, 2015
Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device
Deanna L Kelly, Hadar Ben-Yoav, Gregory F Payne, et al.
Journal of Clinical Psychopharmacology
|
April 26, 2020
The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G
C Renay Friendshuh, Ana Pocivavsek, Haley Demyonovich, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Schizophrenia Research
|
August 30, 2011
Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms
Deanna L Kelly, Gopal Vyas, Charles M Richardson, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
April 20, 2021
Feasibility and patient-reported satisfaction using a novel point-of-care fingerstick method for monitoring absolute neutrophil count for clozapine
Deanna L Kelly, Olga Y Ponomareva, Marie Mackowick, et al.
The Psychiatric Quarterly
|
June 24, 2017
Clozapine in Reducing Aggression and Violence in Forensic Populations
Kathleen Patchan, Gopal Vyas, Ann L Hackman, et al.
Schizophrenia Research
|
July 10, 2012
A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies
Jessica Jackson, William Eaton, Nicola Cascella, et al.
Schizophrenia Research
|
March 31, 2022
Anti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illness
Vincent S Cavaliere, Matthew Glassman, Bethany A DiPaula, et al.
The Psychiatric Quarterly
|
May 4, 2017
Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels
Heidi J Wehring, Teresa Elsobky, Joseph P McEvoy, et al.
Journal of Clinical Psychopharmacology
|
August 15, 2024
Prebiotic Treatment in People With Schizophrenia
Robert W Buchanan, Anne E Werkheiser, Hanna Michel, et al.
Frontiers in Psychiatry
|
December 8, 2025
Case Report: Metabolic, inflammatory, and neurological improvements after a ketogenic diet in a woman with treatment-resistant schizophrenia and metabolic syndrome
Sidney L Murray, Gopal Vyas, Erich Eberhardt, et al.
Clinical Schizophrenia & Related Psychoses
|
July 29, 2015
Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device
Deanna L Kelly, Hadar Ben-Yoav, Gregory F Payne, et al.
Journal of Clinical Psychopharmacology
|
April 26, 2020
The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G
C Renay Friendshuh, Ana Pocivavsek, Haley Demyonovich, et al.
Page
of 3